Castle Biosciences, Inc. (CSTL) Ownership

$17.60

$0.58 (3.41%)
Last update: 04:00 PM EST
Day's range
$17.23
Day's range
$17.67

Castle Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 2.98 M $59.73 M   2.13% 10.43%
VANGUARD GROUP INC 05/09/2025 2.05 M $40.99 M   11.73% 7.16%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 1.47 M $29.39 M   2.24% 5.13%
PORTOLAN CAPITAL MANAGEMENT, LLC 05/15/2025 1.27 M $25.33 M   62.92% 4.42%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 1.20 M $24.03 M   20.09% 4.20%
WASATCH ADVISORS LP 05/15/2025 998.46 K $19.99 M   -44.41% 3.49%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 828.53 K $16.59 M   14.74% 2.90%
STATE STREET CORP 05/15/2025 715.03 K $14.31 M   0.68% 2.50%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 701.20 K $14.04 M   2.37% 2.45%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 676.07 K $13.53 M   65.44% 2.36%
05/12/2025 671.81 K $11.88 M   100.00% 2.35%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 649.85 K $13.01 M   3.45% 2.27%
ALLIANZ ASSET MANAGEMENT GMBH 05/05/2025 639.48 K $12.80 M   98.36% 2.24%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/13/2025 597.09 K $11.91 M   100.00% 2.09%
PARK WEST ASSET MANAGEMENT LLC 05/15/2025 556.49 K $11.14 M   100.00% 1.95%
PALISADE CAPITAL MANAGEMENT, LP 04/29/2025 489.97 K $9.81 M   -2.68% 1.71%
BANK OF AMERICA CORP /DE/ 05/15/2025 375.38 K $7.52 M   -6.98% 1.31%
BRAIDWELL LP 05/15/2025 365.25 K $7.31 M   100.00% 1.28%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2025 350.55 K $7.02 M   15.07% 1.23%
AMERIPRISE FINANCIAL INC 05/14/2025 325.70 K $6.52 M   3.06% 1.14%
BELLEVUE GROUP AG 05/14/2025 301.10 K $6.03 M   -59.64% 1.05%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 279.36 K $5.59 M   28.42% 0.98%
KORNITZER CAPITAL MANAGEMENT INC /KS 05/02/2025 278.31 K $5.57 M   -27.52% 0.97%
NORTHERN TRUST CORP 05/13/2025 273.47 K $5.47 M   -3.91% 0.96%
CITADEL ADVISORS LLC 05/15/2025 258.38 K $5.17 M   -69.04% 0.90%
MILLENNIUM MANAGEMENT LLC 05/15/2025 254.75 K $5.10 M   -53.58% 0.89%
TREXQUANT INVESTMENT LP 05/14/2025 248.99 K $4.98 M   22.31% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 242.26 K $4.85 M   -6.42% 0.85%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 237.70 K $4.76 M   33.89% 0.83%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 236.22 K $4.73 M   -56.82% 0.83%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 04/24/2025 217.79 K $4.36 M   2,070.78% 0.76%
MORGAN STANLEY 05/15/2025 211.79 K $4.24 M   -30.94% 0.74%
ADVISORS CAPITAL MANAGEMENT, LLC 05/27/2025 201.69 K $4.04 M   12.72% 0.71%
SILVERCREST ASSET MANAGEMENT GROUP LLC 05/15/2025 198.80 K $3.98 M   -0.57% 0.69%
D. E. SHAW & CO., INC. 05/15/2025 189.18 K $3.79 M   108.89% 0.66%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/12/2025 176.89 K $3.54 M   4.85% 0.62%
GOLDMAN SACHS GROUP INC 05/16/2025 175.33 K $3.51 M   -59.49% 0.61%
TUDOR INVESTMENT CORP ET AL 05/15/2025 171.38 K $3.43 M   144.57% 0.60%
SHELTON CAPITAL MANAGEMENT 05/15/2025 164.01 K $3.28 M   0.00% 0.57%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 163.16 K $3.27 M   -13.72% 0.57%
ALGERT GLOBAL LLC 05/13/2025 144.31 K $2.89 M   -3.47% 0.50%
TWO SIGMA INVESTMENTS, LP 05/15/2025 139.79 K $2.80 M   100.00% 0.49%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 137.02 K $2.74 M   548.93% 0.48%
FRANKLIN RESOURCES INC 05/13/2025 99.09 K $1.98 M   34.56% 0.35%
SQUAREPOINT OPS LLC 05/15/2025 97.36 K $1.95 M   462.22% 0.34%
BIRCHVIEW CAPITAL, LP 05/15/2025 88.40 K $1.77 M   13.34% 0.31%
BANK OF NEW YORK MELLON CORP 04/29/2025 84.04 K $1.68 M   -0.49% 0.29%
ORION PORTFOLIO SOLUTIONS, LLC 05/15/2025 78.41 K $1.57 M   14.77% 0.27%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2025 77.56 K $1.55 M   575.40% 0.27%
AMERICAN CENTURY COMPANIES INC 05/13/2025 74.07 K $1.48 M   7.07% 0.26%

Castle Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 244 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 2.98 M

VANGUARD GROUP INC: 2.05 M

PRINCIPAL FINANCIAL GROUP INC: 1.47 M

Portolan Capital Management, LLC: 1.27 M

DIMENSIONAL FUND ADVISORS LP: 1.2 M

WASATCH ADVISORS LP: 998,455

90.15% of Castle Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 29.45 M shares in the last 24 months. This purchase volume represents approximately $518.33 M in transactions.